Regional REIT (RGL): Leeds development site sale to Unite Students completed at £12.2m.
Stock up 0.1% to 95.10p at 8.16
RGL announced the sale completion of Merrion Way development site in Leeds for £12.2m to Unite Students, for which an exchange of contracts on a subject-to-planning basis was reported on 10 November 2017.
Read more...Abzena (ABZA): GMP drug substance manufacture for Abzena Inside product released.
Stock flat at 7.40p at 8.16
ABZA has announced the completion of GMP drug substance manufacture for an Abzena Inside product, Clevegen, that was originally humanized utilising ABZA’s Composite Human Antibody Platform.
Read more...
Domino’s Pizza reports operating profits of £48.2m, up 8.1%
On the same day that the BRC reports shoppers scorched off the High Street in tropical conditions, Domino’s, which delivers to homes, picnics, barbecues and beaches has reported a 5.9% rise in first-half like-for-like system sales driving a 6.8% rise in earnings per share to 7.8p.
Read more...Regional REIT (RGL); £50m raised from bond issue; bonds admitted for trading on LSE today
Stock up 1.48% to 95.90p at 8:00
RGL announced the admission of bonds for trading on the London Stock Exchange (LSE) that were issued to successfully raise £50m. The bonds will pay interest at an annual rate of 4.5%, and mature on 6 August 2024.
Read more...Rotork (ROR); 1H18 results; revenue grew 14.8% y/y (OCC); management expectations unchanged
Stock down 2.14% to 347.42p at 8:04
ROR reported 1H18 results, wherein EPS grew 10.3% y/y (OCC 15.3%). Its order book increased 9.1% y/y organically to £364.7m (+13.3% OCC). Revenue rose 10.4% y/y to £331.0m (+14.8 OCC), while underlying operating profit grew 20.2% y/y to £65.4m (+25.1% OCC).
Read more...Ultra Electronics (ULE); 1H18 results; strong order book growth driven by US defence spending
Stock up 1.78% to 1,720p at 8:14
ULE announced its 1H18 results. Its order book increased 19.0% y/y organically to £969.2m, led by higher US defence spending. Revenue decreased 4.2% y/y to £350.5m (+1.3% organically), while underlying operating profit declined 15.2% y/y to £47.9m (+1.4% organically).
Read more...Oxford BioMedica (OXB); signs partnership to develop gene therapy for cystic fibrosis
Stock up 1.49% to 913.42p at 8:01
OXB has entered into collaboration with the UK Cystic Fibrosis Gene Therapy Consortium (GTC) and Imperial Innovations to develop a long-term therapy for patients with cystic fibrosis (CF).
Read more...Augean (AUG); 100,131 new ordinary shares issued at 10p each for exercise of options
Stock down 2.09% to 42.10p at 8:11
AUG announced the issue of 100,131 new ordinary shares of 10p each in the company for exercising of options under a pre-existing share option plan.
Read more...Diverse Income Trust (DIVI); 2018 results: posts NAV total returns of 5.2%
Stock up 0.94% to 107.00p at 8:27
For the year ended 31 May 2018, DIVI posted total shareholder returns of 5.2% compared to FTSE All-Share Index returns of 6.5%. Revenue return per ordinary share for the period was 3.84p compared to 4.02p last year.
Read more...Keywords Studios (KWS); 1H18 trading update: Adjusted PBT up 66%
Stock down 5.49% to 1,686p at 08:21
KWS provided a trading update for the six months ended 30 June 2018. It performed strongly during the first half of the year with preliminary revenues expected to be up 72% to €109.9m (1H17: €63.8m) and adjusted PBT up 66% to €15.9m (1H17: €9.6m).
Read more...